---
title: "Huaxia Eye has repurchased a total of 7.5278 million shares, costing 201 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/224303044.md"
description: "According to the Zhitong Finance APP, Huaxia Eye announced that as of the date of this announcement, the company has repurchased a total of 7.5278 million shares through centralized bidding, accounting for 0.90% of the company's current total share capital, with a total transaction amount of 201 million yuan (excluding transaction fees)"
datetime: "2025-01-08T10:18:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/224303044.md)
  - [en](https://longbridge.com/en/news/224303044.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/224303044.md)
generator: "portal-rs"
---

# Huaxia Eye has repurchased a total of 7.5278 million shares, costing 201 million yuan

According to the Zhitong Finance APP, Huaxia Eye (301267.SZ) announced that as of the date of this announcement, the company has repurchased a total of 7.5278 million shares through centralized bidding, accounting for 0.90% of the company's current total share capital, with a total transaction amount of 201 million yuan (excluding transaction fees)

### Related Stocks

- [301267.CN](https://longbridge.com/en/quote/301267.CN.md)

## Related News & Research

- [Endovia Health opens FDA INAD file for CannEpil veterinary program](https://longbridge.com/en/news/296915045.md)
- [MedicalRite Announces COVID-19 & Flu Combo Test for Better Health](https://longbridge.com/en/news/297204162.md)
- [Frontieras North America Highlights Aug. 27 Reg A+ Offering Deadline, Advances West Virginia FASForm Facility](https://longbridge.com/en/news/297213635.md)
- [IBA publishes H1 2026 results presentation](https://longbridge.com/en/news/297180350.md)
- [CSPC says FDA clears RSV vaccine candidate SYS 6057 for US clinical trial](https://longbridge.com/en/news/296903628.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**